Cargando…
Impulsivity and Stillness: NADA, Pharmaceuticals, and Psychotherapy in Substance Use and Other DSM 5 Disorders
Pharmaceuticals and psychotherapy are commonly used in the management of impulsivity. The National Acupuncture Detoxification Association (NADA) protocol is an adjunctive therapy that involves the bilateral insertion of 1 to 5 predetermined ear needle points. One of the main benefits reported by pat...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695777/ https://www.ncbi.nlm.nih.gov/pubmed/26703743 http://dx.doi.org/10.3390/bs5040537 |
_version_ | 1782407688826650624 |
---|---|
author | Carter, Kenneth Olshan-Perlmutter, Michelle |
author_facet | Carter, Kenneth Olshan-Perlmutter, Michelle |
author_sort | Carter, Kenneth |
collection | PubMed |
description | Pharmaceuticals and psychotherapy are commonly used in the management of impulsivity. The National Acupuncture Detoxification Association (NADA) protocol is an adjunctive therapy that involves the bilateral insertion of 1 to 5 predetermined ear needle points. One of the main benefits reported by patients, providers, and programs utilizing NADA is the sense of stillness, centering, and well-being. The induction of this attitude is seen as contributing to improved clinical outcomes including engagement and retention. The attitude of stillness is also suggestive of a pathway to mitigating impulsivity. Impulsivity is associated with substance use disorders and other DSM 5 diagnoses. Impulsivity has characteristics that are manifested clinically in behaviors such as disinhibition, poor self-control, lack of deliberation, thrill seeking, risk-taking. NADA holds promise as a useful treatment adjunct in the comprehensive management of disorders for which impulsivity is a prominent component. |
format | Online Article Text |
id | pubmed-4695777 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-46957772016-01-19 Impulsivity and Stillness: NADA, Pharmaceuticals, and Psychotherapy in Substance Use and Other DSM 5 Disorders Carter, Kenneth Olshan-Perlmutter, Michelle Behav Sci (Basel) Article Pharmaceuticals and psychotherapy are commonly used in the management of impulsivity. The National Acupuncture Detoxification Association (NADA) protocol is an adjunctive therapy that involves the bilateral insertion of 1 to 5 predetermined ear needle points. One of the main benefits reported by patients, providers, and programs utilizing NADA is the sense of stillness, centering, and well-being. The induction of this attitude is seen as contributing to improved clinical outcomes including engagement and retention. The attitude of stillness is also suggestive of a pathway to mitigating impulsivity. Impulsivity is associated with substance use disorders and other DSM 5 diagnoses. Impulsivity has characteristics that are manifested clinically in behaviors such as disinhibition, poor self-control, lack of deliberation, thrill seeking, risk-taking. NADA holds promise as a useful treatment adjunct in the comprehensive management of disorders for which impulsivity is a prominent component. MDPI 2015-11-26 /pmc/articles/PMC4695777/ /pubmed/26703743 http://dx.doi.org/10.3390/bs5040537 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Carter, Kenneth Olshan-Perlmutter, Michelle Impulsivity and Stillness: NADA, Pharmaceuticals, and Psychotherapy in Substance Use and Other DSM 5 Disorders |
title | Impulsivity and Stillness: NADA, Pharmaceuticals, and Psychotherapy in Substance Use and Other DSM 5 Disorders |
title_full | Impulsivity and Stillness: NADA, Pharmaceuticals, and Psychotherapy in Substance Use and Other DSM 5 Disorders |
title_fullStr | Impulsivity and Stillness: NADA, Pharmaceuticals, and Psychotherapy in Substance Use and Other DSM 5 Disorders |
title_full_unstemmed | Impulsivity and Stillness: NADA, Pharmaceuticals, and Psychotherapy in Substance Use and Other DSM 5 Disorders |
title_short | Impulsivity and Stillness: NADA, Pharmaceuticals, and Psychotherapy in Substance Use and Other DSM 5 Disorders |
title_sort | impulsivity and stillness: nada, pharmaceuticals, and psychotherapy in substance use and other dsm 5 disorders |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695777/ https://www.ncbi.nlm.nih.gov/pubmed/26703743 http://dx.doi.org/10.3390/bs5040537 |
work_keys_str_mv | AT carterkenneth impulsivityandstillnessnadapharmaceuticalsandpsychotherapyinsubstanceuseandotherdsm5disorders AT olshanperlmuttermichelle impulsivityandstillnessnadapharmaceuticalsandpsychotherapyinsubstanceuseandotherdsm5disorders |